Results 31 to 40 of about 423,879 (287)

Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators. [PDF]

open access: yesSci Rep
Urate-lowering treatment (ULT) to target with xanthine oxidase inhibitors (XOIs) paradoxically causes early increase in gouty arthritis flares. Because delayed reduction in flare burden is mechanistically unclear, we tested for ULT inflammation ...
Sanchez C   +6 more
europepmc   +2 more sources

When underlying biology threatens the randomization principle - initial gout flares of urate-lowering therapy. [PDF]

open access: yesNat Rev Rheumatol, 2022
Flare is the dominant feature of gout and occurs because of inflammatory response to monosodium urate crystals; prevention of gout flares should be the major goal of gout care.
Choi HK, Zhang Y, Dalbeth N.
europepmc   +2 more sources

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. [PDF]

open access: yesAnn Rheum Dis, 2023
Objectives To determine the risk of adverse events associated with colchicine or non-steroidal anti-inflammatory drug (NSAID) prophylaxis when initiating allopurinol for gout.
Roddy E   +8 more
europepmc   +2 more sources

Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function:a randomised controlled trial [PDF]

open access: yes, 2020
Background: Allopurinol has vascular antioxidant effects and participates in purinergic signalling within muscle. We tested whether allopurinol could improve skeletal muscle energetics and physical function in older people with impaired physical ...
Cavin, Ian   +10 more
core   +2 more sources

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review [PDF]

open access: diamondGout, Urate, and Crystal Deposition Disease
Gout is the most common inflammatory arthritis. Treatment of gout includes anti-inflammatory and urate-lowering agents. Robust guidelines by the American College of Rheumatology, the European Alliance of Associations for Rheumatology and other committees
Michael Toprover, Michael H. Pillinger
openalex   +2 more sources

Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial [PDF]

open access: yes, 2020
Introduction: Gout is a painful form of inflammatory arthritis associated with several comorbidities, particularly cardiovascular disease. Cherries, which are rich in anti-inflammatory and antioxidative bioactive compounds, are proposed to be efficacious
Barker, Margo E   +3 more
core   +2 more sources

Urate-lowering therapy is associated with a reduced risk of arrhythmias: a systematic review and meta-analysis. [PDF]

open access: yesJ Rheum Dis, 2023
Objective While urate-lowering therapy (ULT) is linked to increased cardioprotective benefits on primary prevention of cardiovascular events such myocardial infarction or heart failure, little is known regarding their effects on arrhythmia risk.
Waitayangkoon P   +8 more
europepmc   +2 more sources

The role of urate and xanthine oxidase in vascular oxidative stress:Future directions [PDF]

open access: yes, 2009
Vascular oxidative stress has been shown to be a potent factor in the pathophysiology of endothelial dysfunction. Despite current optimal evidence-based therapy, mortality from various cardiovascular disorders remains high.
George, Jacob, Struthers, Allan
core   +5 more sources

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. [PDF]

open access: yes, 2016
BackgroundExcess body burden of uric acid promotes gout. Diminished renal clearance of uric acid causes hyperuricemia in most patients with gout, and the renal urate transporter (URAT)1 is important for regulation of serum uric acid (sUA) levels.
Girardet, Jean-Luc   +12 more
core   +2 more sources

Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway

open access: yesNutrition & Metabolism, 2021
Objectives The study of sex differences in hyperuricemia can provide not only a theoretical basis for this clinical phenomenon but also new therapeutic targets for urate-lowering therapy.
Lei Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy